Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows

v3.10.0.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
3 Months Ended
Dec. 31, 2018
Dec. 31, 2017
OPERATING ACTIVITIES    
Net loss $ (2,148,798) $ (4,257,152)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 42,554 44,229
Amortization of intangible assets 77,309 68,816
Noncash interest expense 1,278,423  
Share-based compensation 417,256 207,454
Deferred income taxes 48,144 (3,297,000)
Loss on settlement of accounts receivable   3,764,137
Change in fair value of derivative liabilities (225,000)  
Other 20,413 (5,000)
Changes in current assets and liabilities:    
Decrease in accounts receivable 1,485,536 3,248,628
Increase in inventory (418,522) (299,112)
(Increase) decrease in prepaid expenses and other assets (58,810) 46,671
Decrease in accounts payable (1,231,443) (168,347)
Decrease in unearned revenue (153,357) (24,501)
(Decrease) increase in accrued expenses and other current liabilities (640,186) 967,839
Net cash (used in) provided by operating activities (1,506,481) 296,662
INVESTING ACTIVITIES    
Capital expenditures   (1,914)
Net cash used in investing activities   (1,914)
FINANCING ACTIVITIES    
Proceeds from sale of shares in public offering , net of fees and costs 9,285,432  
Installment payments on SWK credit agreement (2,559,277)  
Net cash provided by financing activities 6,726,155  
Net increase in cash 5,219,674 294,748
CASH AT BEGINNING OF PERIOD 3,759,509 3,277,602
CASH AT END OF PERIOD 8,979,183 3,572,350
Schedule of noncash investing and financing activities:    
Shares issued in connection with common stock purchase agreement   347,081
Increase in deferred assets from accrued expenses   $ 75,920
Costs related to common stock offering in accounts payable $ 153,465